GLENMARK PHARMACEUTICALS
Back to Balance Sheet
|
GLENMARK PHARMACEUTICALS Last 5 Year Total Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Assets | ₹11,300 Cr | ₹9,295 Cr | ₹7,428 Cr | ₹8,424 Cr | ₹8,282 Cr |
What is the latest Total Current Assets ratio of GLENMARK PHARMACEUTICALS ?
| Year | Total Current Assets |
|---|---|
| Mar2026 | ₹11,300 Cr |
| Mar2025 | ₹9,295 Cr |
| Mar2024 | ₹7,428 Cr |
| Mar2023 | ₹8,424 Cr |
| Mar2022 | ₹8,282 Cr |
How is Total Current Assets of GLENMARK PHARMACEUTICALS Trending?
| Years | Total Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹11,300 Cr | 21.56 | |
| Mar2025 | ₹9,295 Cr | 25.14 | |
| Mar2024 | ₹7,428 Cr | -11.82 | |
| Mar2023 | ₹8,424 Cr | 1.71 | |
| Mar2022 | ₹8,282 Cr | - | |
Compare Total Current Assets of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹65,075.3 Cr | -0.9% | 4.6% | 13.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -0.9% |
4.6% |
13.8% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses